Gene expression profiles of two accelerations in a CML patient.
Fiser
Karel
K
Institute of Hematology and Blood Transfusion, Department of Molecular Genetics, U Nemocnice 1, 12820 Prague, Czech Republic. Karel.Fiser@uhkt.cz
Klamová
Hana
H
Moravcová
Jana
J
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage; D001752:Blast Crisis / Q000188:drug therapy / Q000235:genetics* / Q000473:pathology; D003561:Cytarabine / Q000008:administration & dosage; D020869:Gene Expression Profiling / Q000379:methods; D015973:Gene Expression Regulation, Leukemic / Q000187:drug effects; D016179:Granulocyte Colony-Stimulating Factor / Q000008:administration & dosage; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy / Q000235:genetics* / Q000473:pathology; D008297:Male; D008942:Mitoxantrone / Q000008:administration & dosage; D005810:Multigene Family / Q000235:genetics*; D020411:Oligonucleotide Array Sequence Analysis / Q000379:methods; D014740:Vidarabine / Q000008:administration & dosage / Q000031:analogs & derivatives
D003561:Cytarabine; D016179:Granulocyte Colony-Stimulating Factor; D008942:Mitoxantrone; D014740:Vidarabine